Overview of project The bulletins, which are published under the title Effective Health Care, are premised on the belief that scientific evidence of proved effectiveness and acceptability criteria should play an increasingly important part in decisions to purchase or provide particular services. The chosen topics will relate to areas where purchasers most need information and are likely to seek to encourage service changes. The first two target interventions -osteoporosis and rehabilitation after stroke -were selected by a steering group comprising purchasing managers; public health physicians; a FHSA general manager; and staff from CHE, the RCP, and the research team. They were selected according to the following criteria: the intervention has a high resource implications; uncertainty or dispute exists over its effectiveness; the intervention probably has a large impact on health gain; and it has implications for both primary and secondary services. Ideas for future topics have been sought from recipients of the first bulletin.
Widely distributed to purchasers and providers and to professional, voluntary, and patient groups through direct mailing and the network of the RCP, the bulletins are, however, only one means of disseminating reviews on effectiveness and acceptability: workshops will aim at gaining commitment to the guidance provided by the bulletins, at helping in its translation to a local setting, and thus at facilitating the process of change. Secondly, once the clinical effectiveness of the intervention has been established, the costs must be seriously investigated. The general approach outlined by Drummond et al9 is used to evaluate published economic appraisals (box 3). In many instances, however, an economic appraisal may be lacking. Attempts will be made to provide insight into cost implications and indicate specifically the need for further research. Attention will focus not only on the economic consequences to the health services but also to the community, other sectors, and the patient.
Thirdly, the potential acceptability of the target intervention is assessed. From a clinical perspective this relates to the notions of compliance and uptake ("will patients comply with the treatment regimen or attend the screening programme?") More broadly, take up of a service reflects consumer perceptions of the acceptability of the intervention. Attitudes and perceptions about the clinical condition and side effects of the intervention will affect the demand for and utilisation of services. Though many of the studies of consumer acceptability are probably in the form of surveys or ethnographic accounts of care or of illness, or both (and thus may not be widely perceived in the medical arena as presenting "hard" evidence) they must be taken into account in providing health care services. If compliance for an effective intervention is expected to be low ways of enhancing its acceptability must be addressed. The final stage in the review and synthesis process is to make an informed judgement of the overall effectiveness and acceptability of the intervention and its likely impact and to identify gaps in knowledge. Firstly, the balance of risks and benefits must be assessed: "will the intervention do more good than harm?" Possible adverse effects of the intervention are considered and thus potential increases in the incidence of non-target 
